Connect Biopharma Holdings
CNTB
13 hedge funds and large institutions have $1.56M invested in Connect Biopharma Holdings in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 2 closing their positions.
0.64% less ownership
Funds ownership: 5.76% → 5.12% (-0.64%)
7% less funds holding
Funds holding: 14 → 13 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
64% less capital invested
Capital invested by funds: $4.37M → $1.56M (-$2.82M)
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$9.54K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$3.71K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$224K |
| 2 |
CCG
Catalina Capital Group
Torrance,
California
|
-$66.1K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$37.1K |
| 4 |
Renaissance Technologies
New York
|
-$18.4K |
| 5 |
GM
GeoWealth Management
Chicago,
Illinois
|
-$15.1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BCM
1
BML Capital Management
Zionsville,
Indiana
| $1.15M | – | – | – |
|
|
UOC
2
UBS O'Connor
Chicago,
Illinois
| $148K | -$224K | -241,755 | -47% |
|
|
CL
3
Choreo LLC
Rockford,
Illinois
| $88.5K | – | – | – |
|
|
4
Renaissance Technologies
New York
| $63.1K | -$18.4K | -19,897 | -15% |
|
|
CC
5
Callan Capital
La Jolla,
California
| $44K | – | – | – |
|
|
6
Royal Bank of Canada
Toronto,
Ontario, Canada
| $22K | -$37.1K | -40,000 | -50% |
|
7
Geode Capital Management
Boston,
Massachusetts
| $15.4K | – | – | – |
|
8
Commonwealth Equity Services
Waltham,
Massachusetts
| $11K | – | – | – |
|
|
ACM
9
ADAR1 Capital Management
Austin,
Texas
| $5.67K | +$9.54K | +10,300 | New |
|
|
10
UBS Group
Zurich,
Switzerland
| $4.81K | +$3.71K | +4,006 | +85% |
|
11
RhumbLine Advisers
Boston,
Massachusetts
| $1.3K | -$6.61K | -7,130 | -75% |
|
12
JP Morgan Chase
New York
| $67 | – | – | – |
|
|
SS
13
SBI Securities
Tokyo,
Japan
| $3 | – | – | – |
|
|
CCG
14
Catalina Capital Group
Torrance,
California
| – | -$66.1K | -47,867 | Closed |
|
|
GM
15
GeoWealth Management
Chicago,
Illinois
| – | -$15.1K | -10,942 | Closed |
|
CNTB Hedge Fund Activity: Q1 2025 in Review
13 of the 7,457 institutional investors tracked by Wall St. Rank reported a position in Connect Biopharma Holdings (CNTB) for Q1 2025, worth a combined $1.56M — down 64% from $4.37M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of CNTB and 1 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 1 added.
The largest buyer was ADAR1 Capital Management, opening a new position worth an estimated $9.54K. The largest seller was UBS O'Connor, cutting an estimated $224K.
- 13 institutional investors held Connect Biopharma Holdings (CNTB) as of Q1 2025, down from 14 in Q4 2024.
- Funds reported $1.56M of Connect Biopharma Holdings stock for Q1 2025, down 64% quarter-over-quarter.
- 1 fund opened new Connect Biopharma Holdings positions in Q1 2025 and 2 closed out, a net change of -1 holder.
- The largest Connect Biopharma Holdings buyer in Q1 2025 was ADAR1 Capital Management, an estimated $9.54K added.
- The largest Connect Biopharma Holdings seller in Q1 2025 was UBS O'Connor, an estimated $224K sold.
Based on aggregated 13F filings for Q1 2025.